Back

Integrated Pre-discharge Echocardiographic Parameters and Soluble suppression of tumorigenesis 2 (sST2) level to predict Outcomes of non-ischemic acute heart failure

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Thanyaluck Sotananusak

Ramathibodi Chakri Naruebodindra Hospital, Samut Prakan (Thailand)

17 More presentations in this session

Presentation thumbnail
The inpatient costs of heart failure in Japan: evidence from the JROAD and JROAD-DPC registry
Mr K. Kanaoka (Suita, JP)
Abstract
Presentation thumbnail
Comparison of Characteristics and 3-Year Outcomes in Patients with Acute Heart Failure with Preserved, Mid-range, and Reduced Ejection Fraction
Professor H. Cho (Seoul, KR)
Abstract Slides
Presentation thumbnail
Troponin and Lung Impedance based model for prediction 30 and 90-day Heart Failure readmission
Professor M. Kleiner Shochat (Hadera, IL)
Abstract Slides
Presentation thumbnail
Thirty-day readmission as an important target of quality of care after discharge due to acute heart failure. The role of a more efficient hospitalization
Doctor A. Mortara (Monza, IT)
Abstract
Presentation thumbnail
Heart Failure Registries: Worldwide comparison including Colombia
Doctor M. Montes (Cali, CO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Acute Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources